BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24835062)

  • 1. Stakeholder analysis: a useful tool for biobank planning.
    Bjugn R; Casati B
    Biopreserv Biobank; 2012 Jun; 10(3):239-44. PubMed ID: 24835062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Access arrangements' for biobanks: a fine line between facilitating and hindering collaboration.
    Fortin S; Pathmasiri S; Grintuch R; Deschênes M
    Public Health Genomics; 2011; 14(2):104-14. PubMed ID: 20689244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
    Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
    Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Business Planning for a Campus-Wide Biobank.
    Tarling TE; Lasser F; Carter C; Matzke LA; Dhugga G; Arora N; Dee S; LeBlanc J; Babinsky S; O'Donoghue S; Cheah S; Watson P; Vercauteren SM
    Biopreserv Biobank; 2017 Feb; 15(1):37-45. PubMed ID: 28151006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current practices for access, compensation, and prioritization in biobanks. Results from an interview study.
    Langhof H; Kahrass H; Illig T; Jahns R; Strech D
    Eur J Hum Genet; 2018 Nov; 26(11):1572-1581. PubMed ID: 30089824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding the Path to Biobank Sustainability Through Sound Business Planning.
    Henderson M; Simeon-Dubach D; Albert M
    Biopreserv Biobank; 2015 Dec; 13(6):385-6. PubMed ID: 26697906
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustainability in a Hospital-Based Biobank and University-Based DNA Biorepository: Strategic Roadmaps.
    Seiler CY; Eschbacher J; Bowser R; LaBaer J
    Biopreserv Biobank; 2015 Dec; 13(6):401-9. PubMed ID: 26697909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biobanking 3.0: evidence based and customer focused biobanking.
    Simeon-Dubach D; Watson P
    Clin Biochem; 2014 Mar; 47(4-5):300-8. PubMed ID: 24406300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Academic Biobank Value and Sustainability Through an Outputs Focus.
    Rush A; Catchpoole DR; Ling R; Searles A; Watson PH; Byrne JA
    Value Health; 2020 Aug; 23(8):1072-1078. PubMed ID: 32828220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biobank Finances: A Socio-Economic Analysis and Review.
    Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
    Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Market-driven production of biospecimens and the role of NHS hospital-led biobanks.
    Timmons S; Vezyridis P
    Sociol Health Illn; 2017 Sep; 39(7):1242-1257. PubMed ID: 28555937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization.
    Cervo S; De Paoli P; Perin T; Canzonieri V; Steffan A
    Int J Biol Markers; 2015 May; 30(2):e243-51. PubMed ID: 25744364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the financial, operational, and social sustainability of a biobank: the Wales Cancer Bank case study.
    Parry-Jones A
    Biopreserv Biobank; 2014 Dec; 12(6):381-8. PubMed ID: 25496149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the German Biobank Node as Coordinating Institution of the German Biobank Alliance: Engaging with Stakeholders via Survey Research.
    Klingler C; von Jagwitz-Biegnitz M; Hartung ML; Hummel M; Specht C
    Biopreserv Biobank; 2020 Apr; 18(2):64-72. PubMed ID: 31859533
    [No Abstract]   [Full Text] [Related]  

  • 15. The challenge of sustaining a hospital-based biobank and core molecular laboratory: the Beaumont experience.
    Wilson GD; D'Angelo K; Pruetz BL; Geddes TJ; Larson DM; Akervall J
    Biopreserv Biobank; 2014 Oct; 12(5):306-11. PubMed ID: 25314610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost model for biobanks.
    Gonzalez-Sanchez MB; Lopez-Valeiras E; Morente MM; Fernández Lago O
    Biopreserv Biobank; 2013 Oct; 11(5):272-7. PubMed ID: 24835258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The implementation of a Biobank network for Chile].
    Ríos JA; Alcalde E; Ramírez E; Campbell M; Labbé TP; Becerra S; Santander S; Cabrera ME
    Rev Med Chil; 2019 Jul; 147(7):901-909. PubMed ID: 31859989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Start-up of a clinical sample processing, storage and management platform: organisation and development of the REDinREN Biobank.
    Calleros L; Cortés MA; Luengo A; Mora I; Guijarro B; Martín P; Ortiz-Arduán A; Selgas R; Rodríguez-Puyol D; Rodríguez-Puyol M
    Nefrologia; 2012; 32(1):28-34. PubMed ID: 22294002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustainability of Biobanks in the Future.
    De Souza YG
    Adv Exp Med Biol; 2015; 864():29-35. PubMed ID: 26420611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A framework for biobank sustainability.
    Watson PH; Nussbeck SY; Carter C; O'Donoghue S; Cheah S; Matzke LA; Barnes RO; Bartlett J; Carpenter J; Grizzle WE; Johnston RN; Mes-Masson AM; Murphy L; Sexton K; Shepherd L; Simeon-Dubach D; Zeps N; Schacter B
    Biopreserv Biobank; 2014 Feb; 12(1):60-8. PubMed ID: 24620771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.